Sarcopenia is a bad harbinger of cancer-related survival in rectal cancer
Sema Yilmaz Rakici, Rahmi Atil Aksoy, Gulen Burakgazi, Ozlem Terzi, Esra Aydin, Zihni Acar Yazici, Nilgun Ozbek Okumus · 2025
Read Sarcopenia is a bad harbinger of cancer-related survival in rectal cancer by Sema Yilmaz Rakici, Rahmi Atil Aksoy, Gulen Burakgazi, Ozlem Terzi, Esra Aydin, Zihni Acar Yazici, Nilgun Ozbek Okumus (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-12720608.txt.
Description
Sema Yilmaz Rakici and six co-authors link muscle wasting to worse survival in rectal cancer, in a two thousand twenty-five oncology paper. Sarcopenia was assessed jointly from imaging and blood markers rather than either alone.
Patients who died were older and had smaller pre-treatment muscle, subcutaneous fat, and visceral fat volumes than survivors. Larger volumes above derived cutoffs meant longer survival. Low albumin and high Fib-4 fibrosis scores also predicted death, and post-treatment albumin was the lone independent prognostic factor in multivariate analysis. Complete responders carried notably higher albumin. The authors propose the combined profile as a sarcopenia warning system during neoadjuvant therapy.
Catalog record
| CREATOR | Sema Yilmaz Rakici, Rahmi Atil Aksoy, Gulen Burakgazi, Ozlem Terzi, Esra Aydin, Zihni Acar Yazici, Nilgun Ozbek Okumus |
|---|---|
| YEAR | 2025 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 40 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |